NDC 15631-0613

KALI SULPHURICUM

Kali Sulphuricum

KALI SULPHURICUM is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Potassium Sulfate.

Product ID15631-0613_54a1388e-f4d5-4960-ba9a-956b28d0f0ad
NDC15631-0613
Product TypeHuman Otc Drug
Proprietary NameKALI SULPHURICUM
Generic NameKali Sulphuricum
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-12-07
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NamePOTASSIUM SULFATE
Active Ingredient Strength1 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0613-7

10000 TABLET in 1 CONTAINER (15631-0613-7)
Marketing Start Date2015-12-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0613-0 [15631061300]

KALI SULPHURICUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-07
Inactivation Date2020-01-31

NDC 15631-0613-2 [15631061302]

KALI SULPHURICUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-07
Inactivation Date2020-01-31

NDC 15631-0613-3 [15631061303]

KALI SULPHURICUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-07
Inactivation Date2020-01-31

NDC 15631-0613-7 [15631061307]

KALI SULPHURICUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-07
Inactivation Date2020-01-31

NDC 15631-0613-4 [15631061304]

KALI SULPHURICUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-07
Inactivation Date2020-01-31

NDC 15631-0613-6 [15631061306]

KALI SULPHURICUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-07
Inactivation Date2020-01-31

NDC 15631-0613-1 [15631061301]

KALI SULPHURICUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-07
Inactivation Date2020-01-31

NDC 15631-0613-5 [15631061305]

KALI SULPHURICUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-07
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
POTASSIUM SULFATE1 [hp_X]/1

OpenFDA Data

SPL SET ID:66e3a12e-f095-48c5-8ae4-c3ff55240af8
Manufacturer
UNII
UPC Code
  • 8907460005526
  • NDC Crossover Matching brand name "KALI SULPHURICUM" or generic name "Kali Sulphuricum"

    NDCBrand NameGeneric Name
    0220-2921Kali sulphuricumPOTASSIUM SULFATE
    0220-2973Kali sulphuricumPOTASSIUM SULFATE
    0220-2974Kali sulphuricumPOTASSIUM SULFATE
    0220-2975Kali sulphuricumPOTASSIUM SULFATE
    0220-2976Kali sulphuricumPOTASSIUM SULFATE
    0220-2977Kali sulphuricumPOTASSIUM SULFATE
    0220-2978Kali sulphuricumPOTASSIUM SULFATE
    0220-2979Kali sulphuricumPOTASSIUM SULFATE
    0360-0241KALI SULPHURICUMKALI SULPH
    0360-0243KALI SULPHURICUMKALI SULPH
    15631-0254KALI SULPHURICUMKALI SULPHURICUM
    15631-0613KALI SULPHURICUMKALI SULPHURICUM
    37662-2182Kali SulphuricumKali Sulphuricum
    37662-2183Kali SulphuricumKali Sulphuricum
    37662-2184Kali SulphuricumKali Sulphuricum
    37662-2185Kali SulphuricumKali Sulphuricum
    37662-2186Kali SulphuricumKali Sulphuricum
    37662-2187Kali SulphuricumKali Sulphuricum
    37662-2188Kali SulphuricumKali Sulphuricum
    37662-2189Kali SulphuricumKali Sulphuricum
    60512-8023KALI SULPHURICUMKALI SULPHURICUM
    60512-8024KALI SULPHURICUMKALI SULPHURICUM
    62106-5110KALI SULPHURICUMPotassium sulfate
    63083-8007Kali SulphuricumKali Sulphuricum
    68428-457Kali sulphuricumPOTASSIUM SULFATE
    71753-8007Kali SulphuricumKali Sulphuricum
    71919-389Kali sulphuricumPOTASSIUM SULFATE
    71919-745KALI SULPHURICUMPOTASSIUM SULFATE
    44911-0354Kali SulphKali Sulphuricum

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.